Current trend in pneumococcal serotype distribution in Asia

Journal of Vaccines and Vaccination

Volumn 5, Issue SPEC. ISSUE, 2014, Pages

  Le, Cheng Foh ^a   Yusof, Mohd Yasim Mohd ^a   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Antimicrobial resistance; Asia; Clonal complex; Pneumococcal conjugate vaccine; Pneumococcal disease; Serotype distribution; Streptococcus pneumonia

Indexed keywords

EID: 84907344872     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.S2-001     Document Type: Article

References (193)

1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE (2005) WHO estimates of the causes of death in children. Lancet 365: 1147-1152.
2. Klein JO (1994) Otitis media. Clin Infect Dis 19: 823-833.
3. Mulholland K (1999) Magnitude of the problem of childhood pneumonia. Lancet 354: 590-592.
4. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, et al. (1997) Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 337: 970-976.
5. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper (2007) Wkly Epidemiol Rec 82: 93-104.
6. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, et al. (2007) Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 45: 1225-1233.
7. Jin P, Kong F, Xiao M, Oftadeh S, Zhou F, et al. (2009) First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 200: 1375-1380.
8. Calix JJ, Nahm MH (2010) A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J Infect Dis 202: 29-38.
9. Hanage WP, Auranen K, Syrjanen R, Herva E, Makela PH, et al. (2004) Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun 72: 76-81.
10. Hausdorff WP, Feikin DR, Klugman KP (2005) Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5: 83-93.
11. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R (2006) Sitespecific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 25: 602-607.
12. Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, et al. (2002) Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 21: 1008-1016.
13. Rodgers GL, Arguedas A, Cohen R, Dagan R (2009) Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 27: 3802-3810.
14. Ogilvie I, Khoury AE, Cui Y, Dasbach E, Grabenstein JD, et al. (2009) Costeffectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions. Vaccine 27: 4891-4904.
15. Moberley SA, Holden J, Tatham DP, Andrews RM (2008) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev: CD000422.
16. Temple K, Greenwood B, Inskip H, Hall A, Koskela M, et al. (1991) Antibody response to pneumococcal capsular polysaccharide vaccine in African children. Pediatr Infect Dis J 10: 386-390.
17. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, et al. (1991) The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 325: 1453-1460.
18. Huss A, Scott P, Stuck AE, Trotter C, Egger M (2009) Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 180: 48-58.
19. Overweg K, Sluijter M, Srodzinski M, de Groot R, Hermans PW (2000) Immuneprotective antibodies against capsular polysaccharides do not affect natural competence of Streptococcus pneumoniae: implications for current conjugate vaccination strategies? FEMS Immunol Med Microbiol 29: 183-185.
20. Brandao AP, de Oliveira TC, de Cunto Brandileone MC, Goncalves JE, Yara TI, et al. (2004) Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil. Vaccine 23: 762-768.
21. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis (2000). Pediatrics 106: 362-366.
22. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) (2000) MMWR Recomm Rep 49: 1-35.
23. Ball P, Make B (1998) Acute exacerbations of chronic bronchitis: an international comparison. Chest 113: 199S-204S.
24. Lynch JP 3rd, Zhanel GG (2009) Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 30: 189-209.
25. Shinefield HR, Black S, Ray P, Chang I, Lewis N, et al. (1999) Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 18: 757-763.
26. Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, et al. (1998) Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101: 604-611.
27. Destefano F, Pfeifer D, Nohynek H (2008) Safety profile of pneumococcal conjugate vaccines: systematic review of pre-and post-licensure data. Bull World Health Organ 86: 373-380.
28. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, et al. (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344: 403-409.
29. Netherlands HCot (2005) Vaccination of infants against pneumococcal infections. The Hague: Health Council of the Netherlands Publication no. 2005/13.
30. Bergsaker MA, Feiring B (2006) Introduction of pneumococcal conjugate vaccine into the Norwegian childhood vaccination programme. Euro Surveill 11: E060202-E060205.
31. Cameron C, Pebody R (2006) Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules. Euro Surveill 11: E060302. 4.
32. Department of Health (2006) Planned changes to the routine Childhood Immunisation Programme.
33. Black S, Shinefield H, Fireman B, Lewis E, Ray P, et al. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19: 187-195.
34. Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14: e197-e209.
35. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, et al. (2007) Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369: 1179-1186.
36. Farrell DJ, Klugman KP, Pichichero M (2007) Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 26: 123-128.
37. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine-United States, 2007. (2010) MMWR Morb Mortal Wkly Rep 59: 253-257.
38. Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, et al. (2004) Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113: 443-449.
39. Ruckinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, et al. (2009) Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 27: 4136-4141.
40. Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, et al. (2008) Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 26: 3277-3281.
41. Dubos F, Marechal I, Husson MO, Courouble C, Aurel M, et al. (2007) Decline in pneumococcal meningitis after the introduction of the heptavalentpneumococcal conjugate vaccine in northern France. Arch Dis Child 92: 1009-1012.
42. Lepoutre A, Varon E, Georges S, Gutmann L, Levy-Bruhl D (2008) Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill 13: 18962.
43. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, et al. (2009) Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 49: 205-212.
44. Roche PW, Krause V, Cook H, Barralet J, Coleman D, et al. (2008) Invasive pneumococcal disease in Australia, 2006. Commun Dis Intell 32: 18-30.
45. Stephens DS, Zughaier SM, Whitney CG, Baughman WS, Barker L, et al. (2005) Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365: 855-863.
46. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. (2003) Decline in invasive pneumococcal disease after the introduction of proteinpolysaccharide conjugate vaccine. N Engl J Med 348: 1737-1746.
47. Dagan R, Klugman KP (2008) Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8: 785-795.
48. Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, et al. (2001) Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis 33: 1489-1494.
49. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, et al. (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354: 1455-1463.
50. Dias R, Canica M (2007) Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol 51: 35-42.
51. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, et al. (2006) Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368: 1495-1502.
52. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, et al. (2004) Communitywide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23: 829-833.
53. Casey JR, Pichichero ME (2004) Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 23: 824-828.
54. Pichichero ME, Casey JR (2007) Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J 26: S12-S16.
55. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, et al. (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196: 1346-1354.
56. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201: 32-41.
57. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal wkly Rep (2005) 54: 893-897.
58. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, et al. (2005) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294: 2043-2051.
59. Imohl M, Reinert RR, van der Linden M (2010) Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states. Int J Med Microbiol 300: 237-247.
60. Lipsitch M (1999) Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 5: 336-345.
61. Obaro SK (2000) Confronting the pneumococcus: a target shift or bullet change? Vaccine 19: 1211-1217.
62. Spratt BG, Greenwood BM (2000) Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356: 1210-1211.
63. Mera R, Miller LA, Fritsche TR, Jones RN (2008) Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist 14: 101-107.
64. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, et al. (2007) Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 26: 461-467.
65. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, et al. (2009) Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis 48: e23-e33.
66. Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, et al. (2010) Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J 29: 294-300.
67. Pichichero ME, Casey JR (2007) Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298: 1772-1778.
68. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, et al. (2007) Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 26: 468-472.
69. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. (2008) MMWR Morb Mortal Wkly Rep 57: 144-148.
70. Normark BH, Ortqvist A, Kalin M, Olsson-Liljequist B, Hedlund J, et al. (2001) Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children. Scand J Infect Dis 33: 848-850.
71. Beall B, McEllistrem MC, Gertz RE Jr, Wedel S, Boxrud DJ, et al. (2006) Preand postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 44: 999-1017.
72. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype-and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432.
73. Enright MC, Spratt BG (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144: 3049-3060.
74. Bean DC, Klena JD (2005) Characterization of major clones of antibioticresistant Streptococcus pneumoniae in New Zealand by multilocus sequence typing. J Antimicrob Chemother 55: 375-378.
75. Shi ZY, Enright MC, Wilkinson P, Griffiths D, Spratt BG (1998) Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. J Clin Microbiol 36: 3514-3519.
76. Zhou J, Enright MC, Spratt BG (2000) Identification of the major Spanish clones of penicillin-resistant pneumococci via the Internet using multilocus sequence typing. J Clin Microbiol 38: 977-986.
77. Coffey TJ, Berron S, Daniels M, Garcia-Leoni ME, Cercenado E, et al. (1996) Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology 142: 2747-2757.
78. Crook DW, Spratt BG (1998) Multiple antibiotic resistance in Streptococcus pneumoniae. Br Med Bull 54: 595-610.
79. Enright MC, Fenoll A, Griffiths D, Spratt BG (1999) The three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain. J Clin Microbiol 37: 3210-3216.
80. Jefferies JM, Smith AJ, Edwards GF, McMenamin J, Mitchell TJ, et al. (2010) Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J Clin Microbiol 48: 87-96.
81. Gertz RE Jr, McEllistrem MC, Boxrud DJ, Li Z, Sakota V, et al. (2003) Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41: 4194-4216.
82. Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, et al. (2008) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197: 1016-1027.
83. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, et al. (2005) Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192: 1988-1995.
84. Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, et al. (2009) Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 64: 507-510.
85. Cherian T (2007) WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26-27 October 2006, Geneva. Vaccine 25: 6557-6564.
86. Hausdorff WP, Dagan R, Beckers F, Schuerman L (2009) Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease. Vaccine 27: 7257-7269.
87. Grijalva CG, Edwards KM (2006) Promises and challenges of pneumococcal conjugate vaccines for the developing world. Clin Infect Dis 43: 680-682.
88. Lucero MG, Nohynek H, Williams G, Tallo V, Simoes EA, et al. (2009) Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 28: 455-462.
89. Scott JA (2007) The preventable burden of pneumococcal disease in the developing world. Vaccine 25: 2398-2405.
90. Lin TY, Shah NK, Brooks D, Garcia CS (2010) Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine 28: 7589-7605.
91. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR (2000) The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 30: 122-140.
92. Hausdorff WP, Bryant J, Paradiso PR, Siber GR (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30: 100-121.
93. Imohl M, Reinert RR, van der Linden M (2010) Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008). Int J Microbiol 2010: 874189.
94. Liu Y, Wang H, Chen M, Sun Z, Zhao R, et al. (2008) Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn Microbiol Infect Dis 61: 256-263.
95. Chen R, Chen Y, Black S, Hao CL, Ding YF, et al. (2010) Antibiotic resistance patterns and serotype distribution in Streptococcus pneumoniae from hospitalized pediatric patients with respiratory infections in Suzhou, China. J Trop Pediatr 56: 204-205.
96. Xue L, Yao K, Xie G, Zheng Y, Wang C, et al. (2010) Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis 50: 741-744.
97. Yao KH, Wang LB, Zhao GM, Zheng YJ, Deng L, et al. (2011) Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Vaccine 29: 2296-2301.
98. Zhang B, Gertz RE Jr, Liu Z, Li Z, Fu W, et al. (2011) Characterization of highly antimicrobial-resistant clinical pneumococcal isolates recovered in a Chinese hospital during 2009-2010. J Med Microbiol.
99. Zhou L, Yu SJ, Gao W, Yao KH, Shen AD, et al. (2011) Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010. Vaccine 29: 7704-7710.
100. Ip M, Nelson EA, Cheuk ES, Sung RY, Li A, et al. (2007) Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illnesses in Hong Kong. J Clin Microbiol 45: 1969-1971.
101. Ho PL, Chiu SS, Ang I, Lau YL (2011) Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. Vaccine 29: 3270-3275.
102. Hon KL, Ip M, Lee K, Nelson EA, Shea KH, et al. (2010) Childhood pneumococcal diseases and serotypes: can vaccines protect? Indian J Pediatr 77: 1387-1391.
103. Center for Health Protection Hong Kong (2011) Inclusion of Pneumococcal Vaccine in Childhood Immunisation Programme.
104. Hsieh YC, Chang KY, Huang YC, Lin HC, Ho YH, et al. (2008) Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. Antimicrob Agents Chemother 52: 2266-2269.
105. Suzuki K, Nishimaki K, Okuyama K, Katoh T, Yasujima M, et al. (2010) Trends in antimicrobial susceptibility of Streptococcus pneumoniae in the Tohoku district of Japan: a longitudinal analysis from 1998 to 2007. Tohoku J Exp Med 220: 47-57.
106. Hotomi M, Billal DS, Kamide Y, Kanesada K, Uno Y, et al. (2008) Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. J Clin Microbiol 46: 3808-3810.
107. Chiba N, Morozumi M, Sunaoshi K, Takahashi S, Takano M, et al. (2010) Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect 138: 61-68.
108. Sakai F, Chiba N, Ono A, Yamagata Murayama S, Ubukata K, et al. (2011) Molecular epidemiologic characteristics of Streptococcus pneumoniae isolates from children with meningitis in Japan from 2007 through 2009. J Infect Chemother 17: 334-340.
109. Oishi T, Wada A, Chang B, Toyabe S, Uchiyama M (2011) Serotyping and multilocus sequence typing of Streptococcus pneumoniae isolates from the blood and posterior nares of Japanese children prior to the introduction of 7-valent pneumococcal conjugate vaccine. Jpn J Infect Dis 64: 341-344.
110. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, et al. (2008) Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 14: 275-281.
111. Song JH, Baek JY, Cheong HS, Chung DR, Peck KR, et al. (2009) Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007. Diagn Microbiol Infect Dis 63: 271-278.
112. Baek JY, Ko KS, Kim SH, Kang CI, Chung DR, et al. (2011) Comparison of genotypes of Streptococcus pneumoniae serotypes 6A and 6B before and after the introduction of PCV7 vaccination in Korea. Diagn Microbiol Infect Dis 69: 370-375.
113. Hsu LY, Lui SW, Lee JL, Hedzlyn HM, Kong DH, et al. (2009) Adult invasive pneumococcal disease pre-and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore. J Med Microbiol 58: 101-104.
114. Jefferies JM, Tee WS, Clarke SC (2011) Molecular analysis of Streptococcus pneumoniae clones causing invasive disease in children in Singapore. J Med Microbiol 60: 750-755.
115. Le CF, Palanisamy NK, Mohd Yusof MY, Sekaran SD (2011) Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia. Plos One 6: e19547.
116. Yasin RM, Zin NM, Hussin A, Nawi SH, Hanapiah SM, et al. (2011) Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals. Vaccine 29: 5688-5693.
117. Srifeungfung S, Tribuddharat C, Comerungsee S, Chatsuwan T, Treerauthanaweeraphong V, et al. (2010) Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009. Vaccine 28: 3440-3444.
118. Baggett HC, Peruski LF, Olsen SJ, Thamthitiwat S, Rhodes J, et al. (2009) Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand. Clin Infect Dis 48: S65-S74.
119. Moore CE, Sengduangphachanh A, Thaojaikong T, Sirisouk J, Foster D, et al. (2010) Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg 83: 451-457.
120. Brooks WA, Breiman RF, Goswami D, Hossain A, Alam K, et al. (2007) Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 77: 795-801.
121. Saha SK, Naheed A, El Arifeen S, Islam M, Al-Emran H, et al. (2009) Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin Infect Dis 48: S75-S81.
122. Arifeen SE, Saha SK, Rahman S, Rahman KM, Rahman SM, et al. (2009) Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clin Infect Dis 48: S103-S113.
123. Ministry of Health (2008) Report on Pneumococcal & Hib Surveillance-2005-2nd quarter 2008.
124. Williams EJ, Thorson S, Maskey M, Mahat S, Hamaluba M, et al. (2009) Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal. Clin Infect Dis 48: S114-S122.
125. Kelly DF, Thorson S, Maskey M, Mahat S, Shrestha U, et al. (2011) The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal. Int J Infect Dis 15: e17-e23.
126. Shah AS, Knoll MD, Sharma PR, Moisi JC, Kulkarni P, et al. (2009) Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network. Clin Infect Dis 48: S123-S128.
127. Rijal B, Tandukar S, Adhikari R, Tuladhar NR, Sharma PR, et al. (2010) Antimicrobial susceptibility pattern and serotyping of Streptococcus pneumoniae isolated from Kanti Children Hospital in Nepal. Kathmandu Univ Med J (KUMJ) 8: 164-168.
128. Zaidi AK, Khan H, Lasi R, Mahesar W (2009) Surveillance of pneumococcal meningitis among children in Sindh, southern Pakistan. Clin Infect Dis 48: S129-S135.
129. Al-Yaqoubi M, Elhag K (2011) Serotype Prevalence and Penicillin-susceptibility of Streptococcus pneumoniae in Oman. Oman Med J 26: 43-47.
130. Percin D, Ay Altintop Y, Sumerkan B (2010) Ten-year surveillance of invasive Streptococcus pneumoniae isolates in central Turkey prior to the introduction of a conjugate vaccine. J Infect Dev Ctries 4: 560-565.
131. Ceyhan M, Yildirim I, Sheppard CL, George RC (2010) Pneumococcal serotypes causing pediatric meningitis in Turkey: application of a new technology in the investigation of cases negative by conventional culture. Eur J Clin Microbiol Infect Dis 29: 289-293.
132. Ceyhan M, Gurler N, Yaman A, Ozturk C, Oksuz L, et al. (2011) Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide. Clin Vaccine Immunol 18: 1028-1030.
133. Kattan R, Abu Rayyan A, Zheiman I, Idkeidek S, Baraghithi S, et al. (2011) Serotype distribution and drug resistance in Streptococcus pneumoniae, Palestinian Territories. Emerg Infect Dis 17: 94-96.
134. Somech I, Dagan R, Givon-Lavi N, Porat N, Raiz S, et al. (2011) Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine. Vaccine 29: 4202-4209.
135. Yao K, Shen X, Yul S, Lu Q, Deng L, et al. (2007) Antimicrobial resistance and serotypes of nasopharyngeal strains of Streptococcus pneumoniae in Chinese children with acute respiratory infections. J Int Med Res 35: 253-267.
136. Zhao GM, Black S, Shinefield H, Wang CQ, Zhang YH, et al. (2003) Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China. Pediatr Infect Dis J 22: 739-742.
137. Center for Health Protection Hong Kong (19 April 2011). Inclusion of Pneumococcal Vaccine in Childhood Immunisation Programme.
138. Center for Health Protection Hong Kong (April 2011) Recommendations on the Use of 13-valent Pneumococcal Conjugate Vaccine in Childhood Immunisation Programme.
139. Ip M, Lyon DJ, Yung RW, Chan C, Cheng AF (1999) Evidence of clonal dissemination of multidrug-resistant Streptococcus pneumoniae in Hong Kong. J Clin Microbiol 37: 2834-2839.
140. Ip M, Lyon DJ, Yung RW, Chan C, Cheng AF (2001) Macrolide resistance in Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 45: 1578-1580.
141. Ip M, Chau SS, Chi F, Cheuk ES, Ma H, et al. (2007) Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and-nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005. Antimicrob Agents Chemother 51: 2192-2194.
142. Hsieh YC, Huang YC, Lin HC, Ho YH, Chang KY, et al. (2009) Characterization of invasive isolates of Streptococcus pneumoniae among Taiwanese children. Clin Microbiol Infect 15: 991-996.
143. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, et al. (2004) Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 190: 1203-1211.
144. Lauderdale TL, Wagener MM, Lin HM, Huang IF, Lee WY, et al. (2006) Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates. Diagn Microbiol Infect Dis 56: 421-426.
145. Lin WJ, Lo WT, Chou CY, Chen YY, Tsai SY, et al. (2006) Antimicrobial resistance patterns and serotype distribution of invasive Streptococcus pneumoniae isolates from children in Taiwan from 1999 to 2004. Diagn Microbiol Infect Dis 56: 189-196.
146. Sjostrom K, Spindler C, Ortqvist A, Kalin M, Sandgren A, et al. (2006) Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 42: 451-459.
147. Sniadack DH, Schwartz B, Lipman H, Bogaerts J, Butler JC, et al. (1995) Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Pediatr Infect Dis J 14: 503-510.
148. Hsueh PR, Teng LJ, Wu TL, Yang D, Huang WK, et al. (2003) Telithromycinand fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data. Antimicrob Agents Chemother 47: 2145-2151.
149. Chiu CH, Su LH, Huang YC, Lai JC, Chen HL, et al. (2007) Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan. Antimicrob Agents Chemother 51: 3404-3406.
150. Chang B, Otsuka T, Iwaya A, Okazaki M, Matsunaga S, et al. (2010) Isolation of Streptococcus pneumoniae serotypes 6C and 6D from the nasopharyngeal mucosa of healthy Japanese children. Jpn J Infect Dis 63: 381-383.
151. Chiba N, Kobayashi R, Hasegawa K, Morozumi M, Nakayama E, et al. (2005) Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. J Antimicrob Chemother 56: 756-760.
152. Ko KS, Song JH (2004) Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes. J Infect Dis 190: 739-747.
153. Vasoo S, Singh K, Chow C, Lin RT, Hsu LY, et al. (2010) Pneumococcal carriage and resistance in children attending day care centers in Singapore in an early era of PCV-7 uptake. J Infect 60: 507-509.
154. Chong CY, Koh-Cheng T, Yee-Hui M, Nancy TW (2008) Invasive pneumococcal disease in Singapore children. Vaccine 26: 3427-3431.
155. Clarke SC, Jefferies JM, Smith AJ, McMenamin J, Mitchell TJ, et al. (2006) Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland. J Med Microbiol 55: 1079-1084.
156. Ding F, Tang P, Hsu MH, Cui P, Hu S, et al. (2009) Genome evolution driven by host adaptations results in a more virulent and antimicrobial-resistant Streptococcus pneumoniae serotype 14. BMC Genomics 10: 158.
157. Rohani MY, Raudzah A, Ng AJ, Ng PP, Zaidatul AA, et al. (1999) Epidemiology of Streptococcus pneumoniae infection in Malaysia. Epidemiol Infect 122: 77-82.
158. Chokephaibulkit K, Srifuengfung S, Mingbanjerdsuk J, Tosasuk K, Vanprapar N, et al. (2000) Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998. Southeast Asian J Trop Med Public Health 31: 498-505.
159. Srifuengfung S, Tribuddharat C, Champreeda P, Daniels J, Chokephaibulkit K, et al. (2008) Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand. Southeast Asian J Trop Med Public Health 39: 461-466.
160. Phetsouvanh R, Phongmany S, Soukaloun D, Rasachak B, Soukhaseum V, et al. (2006) Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg 75: 978-985.
161. Gupta A, Khaw FM, Stokle EL, George RC, Pebody R, et al. (2008) Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school. BMJ 337: a2964.
162. Le Hello S, Watson M, Levy M, Marcon S, Brown M, et al. (2010) Invasive serotype 1 Streptococcus pneumoniae outbreaks in the South Pacific from 2000 to 2007. J Clin Microbiol 48: 2968-2971.
163. Leimkugel J, Adams Forgor A, Gagneux S, Pfluger V, Flierl C, et al. (2005) An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 192: 192-199.
164. Saha SK, Baqui AH, Darmstadt GL, Ruhulamin M, Hanif M, et al. (2003) Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol 41: 5582-5587.
165. Saha SK, Rikitomi N, Biswas D, Watanabe K, Ruhulamin M, et al. (1997) Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995. J Clin Microbiol 35: 785-787.
166. Saha SK, Khan WA, Hoq MS, Salim AF, Akbar MS (1991) Penicillin-resistant pneumococci in Bangladeshi children. Lancet 337: 734-735.
167. Saha SK, Rikitomi N, Ruhulamin M, Masaki H, Hanif M, et al. (1999) Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infections in Bangladesh, 1993 to 1997. J Clin Microbiol 37: 798-800.
168. Leiberman A, Leibovitz E, Piglansky L, Raiz S, Press J, et al. (2001) Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J 20: 260-264.
169. Sazawal S, Black RE (2003) Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 3: 547-556.
170. Batuwanthudawe R, Karunarathne K, Dassanayake M, de Silva S, Lalitha MK, et al. (2009) Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka. Clin Infect Dis 48: S136-S140.
171. World Bank. Nepal at a glance.
172. Dawson P, Pradhan Y, Houston R, Karki S, Poudel D, et al. (2008) From research to national expansion: 20 years' experience of community-based management of childhood pneumonia in Nepal. Bull World Health Organ 86: 339-343.
173. Dobay O, Rozgonyi F, Hajdu E, Nagy E, Knausz M, et al. (2003) Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary. J Antimicrob Chemother 51: 887-893.
174. Michel N, Watson M, Baumann F, Perolat P, Garin B (2005) Distribution of Streptococcus pneumoniae serotypes responsible for penicillin resistance and the potential role of new conjugate vaccines in New Caledonia. J Clin Microbiol 43: 6060-6063.
175. Shibl A, Memish Z, Pelton S (2009) Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt. Int J Antimicrob Agents 33: 410 e411-419.
176. Esel D, Doganay M, Alp E, Sumerkan B (2003) Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome. Clin Microbiol Infect 9: 1038-1044.
177. Ceyhan M, Yildirim I, Balmer P, Borrow R, Dikici B, et al. (2008) A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg Infect Dis 14: 1089-1096.
178. Firat M, Ersoy Y, Esel D, Bayraktar M, Caylan R, et al. (2006) Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients. Mikrobiyol Bul 40: 169-177.
179. Gur D, Guciz B, Hascelik G, Esel D, Sumerkan B, et al. (2001) Streptococcus pneumoniae penicillin resistance in Turkey. J Chemother 13: 541-545.
180. Yalcin I, Gurler N, Alhan E, Yaman A, Turgut M, et al. (2006) Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004. Eur J Pediatr 165: 654-657.
181. Telli M, Eyigor M, Gultekin B, Aydin N (2011) Evaluation of resistance mechanisms and serotype and genotype distributions of macrolide-resistant strains in clinical isolates of Streptococcus pneumonia in Aydin, Turkey. J Infect Chemother 17: 658-664.
182. Sener B, Tunckanat F, Ulusoy S, Tunger A, Soyletir G, et al. (2007) A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005. J Antimicrob Chemother 60: 587-593.
183. de la Campa AG, Ardanuy C, Balsalobre L, Perez-Trallero E, Marimon JM, et al. (2009) Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. Emerg Infect Dis 15: 905-911.
184. Farrell DJ, Couturier C, Hryniewicz W (2008) Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004). Int J Antimicrob Agents 31: 245-249.
185. Gulay Z, Ozbek OA, Bicmen M, Gur D (2008) Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey. Jpn J Infect Dis 61: 490-493.
186. Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, et al. (2005) Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 11: 829-837.
187. Dagan R, Barkai G, Leibovitz E, Dreifuss E, Greenberg D (2006) Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm. Pediatr Infect Dis J 25: 981-986.
188. Greenberg D, Givon-Lavi N, Sharf AZ, Vardy D, Dagan R (2008) The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children. Pediatr Infect Dis J 27: 776-782.
189. Gordon SB, Kanyanda S, Walsh AL, Goddard K, Chaponda M, et al. (2003) Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerg Infect Dis 9: 747-749.
190. Levine OS, O'Brien KL, Knoll M, Adegbola RA, Black S, et al. (2006) Pneumococcal vaccination in developing countries. Lancet 367: 1880-1882.
191. Song JH, Chang HH, Suh JY, Ko KS, Jung SI, et al. (2004) Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 53: 457-463.
192. Song JH, Jung SI, Ko KS, Kim NY, Son JS, et al. (2004) High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48: 2101-2107.
193. Pai R, Gertz RE, Beall B (2006) Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44: 124-131.